Snibe Diagnostic | Briefing, News, Analysis, Research, Data

Snibe Diagnostic

The main business of Shenzhen Snibe Diagnostics is to develop

The main business of Shenzhen Snibe Diagnostics is to develop, produce and sell series of automatic chemiluminescence immunoassay instruments and supporting reagents, and is the leader in this field in China. The company's products are mainly used to provide diagnostic information for disease prevention, diagnosis, treatment monitoring, prognosis observation, health status evaluation and hereditary disease prediction.

Sector

Healthcare

Industry

Biotech/Pharma

Sub-industry

Founded

Dec 1, 1995

HQ location

Guangdong, China

Legal name

Shenzhen New Industries Biomedical Engineering Co., Ltd (Snibe)

Website

http://www.snibe.com

Snibe@snibe.net

Employees

1001-5000

All
News
Analysis
Research

Briefing Feb 16, 2023 12:51 PM · Healthcare

Innovative Drug Developer Rezu Bio Raised CNY 10 Mn in Series Pre-A

Briefing Feb 07, 2023 12:11 PM · Healthcare

ForLong Biotech Nets Over CNY 100 Mn in Series A

In-depth

Healthcare

Chinese Company Turned the Tables on Domestic Cell Culture Media Market

In this article, EqualOcean mainly introduce the history, competition, lead company, future trend in domestic cell culture media industry.

Feb 02, 2023 10:45 AM

Briefing Feb 07, 2023 10:59 AM · Healthcare

CytoCan Corp. Nets CNY 10 Mn in Seed Round

Briefing Jan 30, 2023 10:44 AM · Healthcare

Levostar Completes Pre-A Financing Round to Further Invest in CGT

Research

Healthcare

Digital Therapeutics - Revolution of the healthcare system

Nov 16, 2022 05:19 PM

Research

Healthcare

2022 China AI Health 30 Report

Nov 07, 2022 04:27 PM

Research

Healthcare

2022 China’s Healthcare Industry: An Introductory Handbook

Aug 29, 2022 05:45 PM

Research

Technology, Healthcare, Financials

WIA2020 | 30 Tech Entrepreneurs in China

Apr 22, 2021 03:11 PM

Briefing Jan 18, 2023 10:59 AM · Healthcare

BlissBio Nets Over CNY 100 Mn in Series B+

Briefing Sep 21, 2022 10:38 AM · Healthcare

Weiyou Gene Nets Tens of Millions of CNY in Series Pre-A Round

Briefing Sep 16, 2022 11:10 PM · Healthcare

NaviSeed Nets Tens of millions of CNY in Angel Round

Briefing Sep 13, 2022 05:30 PM · Healthcare

Nuwacell Nets Hundreds of Mns of CNY in Series A

Consumer Staples, Healthcare · Analysis

EqualOcean | Southern Weekly 2022 'China Greenwashing List'

Nine companies have been listed on China's Greenwashing List, drawing wider attention to the issue of greenwashing.

Oct 03, 2023 12:37 PM

Healthcare · Analysis

EqualOcean｜China's Top 20 ESG Performers Among Private Enterprises（Part III）

Private enterprises are actively embracing the transformative era

Sep 28, 2023 10:00 AM

Briefing Aug 31, 2022 08:30 PM · Healthcare

Enitiatebio Nets One Hundred Million of CNY in Series A Round

Briefing Jun 28, 2022 09:56 AM · Healthcare

And platinum medicine b7h4x4-1bb bispecific antibody were approved by FDA for new drug research

Briefing Jun 28, 2022 09:54 AM · Healthcare

Fosun pharma and Amgen have reached cooperation to accelerate the commercialization of two innovative drugs in China

Healthcare

Ligatech Completes D Round of Financing of hundreds of Millions

Recently, Shanghai Ligatech Bioscience Co., Ltd(利格泰), located in Qingpu District, Shanghai, announced the completion of a D round of financing of hundreds of Millions.

Sep 22, 2023 02:45 PM

Healthcare

Lanja has completed the Series A funding of hundred millions CNY

Shanghai Lanja Medical Technology Co., Ltd (“Lanja”) recently has announced the completion of the Series A funding of hundred millions CNY.

Sep 11, 2023 10:04 PM

Briefing Jun 28, 2022 09:50 AM · Healthcare

It is expected to achieve functional cure of chronic hepatitis B! GSK antisense therapy phase IIB positive clinical results

Briefing Jun 28, 2022 09:37 AM · Healthcare

Aibo biology: cooperate with Jiahe biology to jointly develop tumor mRNA drugs

Briefing Jun 24, 2022 11:15 AM · Healthcare

F-star to be acquired by China biopharmaceutical with USD 161million

Briefing Nov 19, 2020 09:35 AM · Healthcare